Ubs Group Ag Gossamer Bio, Inc. Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 2,770,046 shares of GOSS stock, worth $7.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,770,046

Previous 312,742 785.73%

Holding current value

$7.51 Million

Previous $384,000 1797.14%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$1.21 - $3.46 $2.97 Million - $8.5 Million	2,457,304 Added 785.73%	2,770,046 $7.29 Million
Q2 2025 Aug 14, 2025	BUY	$0.78 - $1.44 $72,126 - $133,156	92,470 Added 41.98%	312,742 $384,000
Q1 2025 May 13, 2025	BUY	$0.85 - $1.53 $171,048 - $307,888	201,234 Added 1057.01%	220,272 $242,000
Q4 2024 Feb 14, 2025	SELL	$0.66 - $1.07 $86,326 - $139,952	-130,797 Reduced 87.29%	19,038 $17,000
Q3 2024 Nov 14, 2024	BUY	$0.79 - $1.25 $118,334 - $187,237	149,790 Added 332866.66%	149,835 $148,000

Q2 2024 Aug 13, 2024	SELL	$0.51 - $1.27 $2,794 - $6,959	-5,480 Reduced 99.19%	45 $0
Q1 2024 May 13, 2024	SELL	$0.8 - $1.51 $14,792 - $27,921	-18,491 Reduced 76.99%	5,525 $6,000
Q4 2023 Feb 09, 2024	BUY	$0.48 - $1.08 $10,567 - $23,777	22,016 Added 1100.8%	24,016 $21,000
Q3 2023 Nov 09, 2023	SELL	$0.78 - $1.82 $136,806 - $319,215	-175,393 Reduced 98.87%	2,000 $1,000
Q2 2023 Aug 11, 2023	BUY	$0.98 - $1.53 $3,337 - $5,211	3,406 Added 1.96%	177,393 $212,000
Q1 2023 May 12, 2023	SELL	$0.96 - $2.92 $1.49 Million - $4.54 Million	-1,556,319 Reduced 89.94%	173,987 $219,000
Q4 2022 Feb 08, 2023	BUY	$1.74 - $12.87 $2.96 Million - $21.9 Million	1,699,439 Added 5505.68%	1,730,306 $3.75 Million
Q3 2022 Nov 10, 2022	SELL	$7.21 - $14.88 $598,127 - $1.23 Million	-82,958 Reduced 72.88%	30,867 $370,000
Q2 2022 Aug 10, 2022	SELL	$5.97 - $9.97 $417,738 - $697,630	-69,973 Reduced 38.07%	113,825 $953,000
Q1 2022 May 16, 2022	BUY	$8.44 - $12.49 $155,042 - $229,441	18,370 Added 11.1%	183,798 $1.6 Million
Q4 2021 Feb 14, 2022	BUY	$10.12 - $14.07 $1.05 Million - $1.46 Million	103,453 Added 166.93%	165,428 $1.87 Million
Q3 2021 Nov 15, 2021	BUY	$7.25 - $13.23 $359,150 - $655,387	49,538 Added 398.31%	61,975 $779,000
Q2 2021 Aug 13, 2021	SELL	$8.0 - $9.75 $548,392 - $668,352	-68,549 Reduced 84.64%	12,437 $101,000
Q1 2021 May 12, 2021	BUY	$8.63 - $10.94 $695,431 - $881,578	80,583 Added 19995.78%	80,986 $749,000
Q4 2020 Feb 11, 2021	BUY	$8.3 - $13.59 $2,382 - $3,900	287 Added 247.41%	403 $4,000
Q3 2020 Nov 12, 2020	BUY	$11.3 - $14.75 $1,310 - $1,711	116 New	116 $1,000
Q2 2020 Jul 31, 2020	SELL	$9.52 - $15.98 $38,813 - $65,150	-4,077 Closed	0 $0
Q1 2020 May 01, 2020	SELL	$8.0 - $15.48 $203,576 - $393,919	-25,447 Reduced 86.19%	4,077 $41,000
Q4 2019 Feb 14, 2020	SELL	$14.82 - $26.79 $405,030 - $732,170	-27,330 Reduced 48.07%	29,524 $461,000
Q3 2019 Nov 14, 2019	BUY	$16.02 - $22.47 $96,872 - $135,876	6,047 Added 11.9%	56,854 $955,000
Q2 2019 Aug 14, 2019	BUY	$16.12 - $22.89 $819,008 - $1.16 Million	50,807 New	50,807 $1.13 Million

Others Institutions Holding GOSS

# of Institutions

180

Shares Held

163M

Call Options Held

8.11M

Put Options Held

211K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $255M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account